Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Jordana E. Hoppe"'
Autor:
Annemarie G. Wolfe, Stephanie P. Gilley, Stephanie W. Waldrop, Christina Olson, Emma Harding, Kaitlin Widmer, Lindsey B. Gumer, Matthew Haemer, Jordana E. Hoppe
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2023)
BackgroundUniversal newborn screening changed the way medical providers think about the presentation of cystic fibrosis (CF). Before implementation of universal screening, it was common for children with CF to present with failure to thrive, nutritio
Externí odkaz:
https://doaj.org/article/13a597ec996e4b08bb09b115b3fcd9ff
Publikováno v:
BMC Pulmonary Medicine, Vol 17, Iss 1, Pp 1-8 (2017)
Abstract Background Pulmonary exacerbations (PEx) in school aged children and adults with cystic fibrosis (CF) lead to increased morbidity and lung function decline. However, the effect of exacerbations in young children with CF is not fully understo
Externí odkaz:
https://doaj.org/article/aa29735116fe4a2fbbe4f669e74ee1ab
Publikováno v:
Expert Review of Respiratory Medicine. 17:97-108
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2781f6d55b921f4ad4ff66ab6d439029
https://doi.org/10.1080/17476348.2023.2179989
https://doi.org/10.1080/17476348.2023.2179989
Autor:
Scott D. Sagel, Oren Kupfer, Brandie D. Wagner, Stephanie D. Davis, Sharon D. Dell, Thomas W. Ferkol, Jordana E. Hoppe, Margaret Rosenfeld, Kelli M. Sullivan, Harm A. W. M. Tiddens, Michael R. Knowles, Margaret W. Leigh
Publikováno v:
Annals of the American Thoracic Society. 20:67-74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92f2264d370bafc1a3ac5626b0f68ada
https://doi.org/10.1513/annalsats.202204-314oc
https://doi.org/10.1513/annalsats.202204-314oc
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 206:1308-1310
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2ab1aaa52e65b011c04f85075bd7d56
https://doi.org/10.1164/rccm.202208-1507ed
https://doi.org/10.1164/rccm.202208-1507ed
Autor:
Mark A. Chilvers, Jordana E. Hoppe, Caroline A. Owen, Alexandra G Cornell, Rachel Zahigian, Susanna A McColley, John McNamara, S. Tian, Felix Ratjen
Publikováno v:
The Lancet Respiratory Medicine. 9:977-988
Summary Background A previous phase 3 study showed that lumacaftor–ivacaftor was generally safe and well tolerated over 24 weeks of treatment in children aged 2–5 years with cystic fibrosis homozygous for the F508del-CFTR mutation. In this study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a2f69c39b61569308c37623984506be
https://doi.org/10.1016/s2213-2600(21)00069-2
https://doi.org/10.1016/s2213-2600(21)00069-2
Autor:
Stacey L. Martiniano, Charles R. Esther, Jordana E. Hoppe, Chelsea S Davis, Marianne S. Muhlebach, Elisabeth P. Dellon, Jennifer S. Guimbellot, Demet Toprak, Cori L. Daines
Publikováno v:
Pediatric Pulmonology. 55:2225-2232
This review briefly summarizes presentations in several major topic areas at the conference: pathophysiology and basic science of cystic fibrosis lung disease, clinical trials, clinical quality improvement, microbiology and treatment of infection, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e6fb7f914413386bd5aa4dfdb22dbd1
https://doi.org/10.1002/ppul.24919
https://doi.org/10.1002/ppul.24919
Autor:
Jordana E. Hoppe, Brandie D. Wagner, J. Kirk Harris, Steven M. Rowe, Sonya L Heltshe, Emily M. DeBoer, Scott D. Sagel
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 21(6)
Ivacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator for people with CF and the G551D mutation. We aimed to investigate the biology of CFTR modulation and systemic effects of CFTR restoration by examining changes in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff858ac3a2b037f2a24e9d56740eb757
https://pubmed.ncbi.nlm.nih.gov/35440409
https://pubmed.ncbi.nlm.nih.gov/35440409
Autor:
Sabina Sariyska, Stacey L. Martiniano, Patricia M Lenhart-Pendergrass, M. Anthony, Ashley Andrews, Heather Scavezze, Elinor Towler, Jordana E. Hoppe, Edith T. Zemanick
Publikováno v:
Pediatric pulmonologyREFERENCES. 56(7)
BACKGROUND: Collection of respiratory cultures for airway microbiology surveillance is an essential component of routine clinical care in cystic fibrosis (CF). The COVID-19 global pandemic has necessitated increased use of telehealth, but one limitat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc5e97a3e9ddb859777077fe04531b95
https://pubmed.ncbi.nlm.nih.gov/33847465
https://pubmed.ncbi.nlm.nih.gov/33847465
Publikováno v:
Journal of Cystic Fibrosis
Background Pulmonary exacerbations (PEx) in children with cystic fibrosis (CF) are frequently treated in the outpatient setting with oral antibiotics. However, little is known about the characteristics of PEx managed on an outpatient basis and the ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69d6136db2cd38d868abca771535bd70
https://doi.org/10.1016/j.jcf.2018.05.015
https://doi.org/10.1016/j.jcf.2018.05.015